Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: Secure blockade of ischemic neuronal death

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 1, 2001, Pages 377-384

  Seo, So Young ^a   Yun, Bong Sik ^b   Ryoo, In Ja ^b   Choi, Jun Sub ^c   Joo, Choun Ki ^c   Chang, Su Youne ^d   Chung, Jun Mo ^d   Oh, Seikwan ^b   Gwag, Byoung Joo ^a   Yoo, Ick Dong ^b  

^a Ajou University School of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; COMPLESTATIN; KAINIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; FETUS; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA ISCHEMIA; SYNAPTIC TRANSMISSION;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CALCIUM; CELL DEATH; CHLOROPHENOLS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUCOSE; KAINIC ACID; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; OXIDATIVE STRESS; OXYGEN; PATCH-CLAMP TECHNIQUES; PEPTIDES, CYCLIC; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL VESSELS;

EID: 0034807662     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
2. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors
3. Antagonist profile of 6,7-dichloro-3-hydroxy-2-quinoxalinecarboxylate at excitatory amino acid receptors in the neonatal rat spinal cord
4. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia
5. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
6. Ionic dependence of glutamate neurotoxicity
7. Glutamate neurotoxicity and diseases of the nervous system
8. Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons
9. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked
10. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
11. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate
12. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: Implications for neurodegeneration
13. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias
14. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase
15. N-Methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture
16. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage
17. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures
18. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro
19. Nonsteroidal lazaroid U78517F in models of focal and global ischemia
20. Programmed cell death in prokaryotes
21. Necrosis and apoptosis after retinal ischemia: Involvement of NMDA-mediated excitotoxicity and p53
22. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose
23. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin
24. New diphenazines with neuronal cell protecting activity, phenazostatins A and B, produced by Streptomyces sp
25. Attenuation of focal cerebral ischemic injury in transgenie mice overexpressing CuZn superoxide dismutase
26. Staurosporine-induced neuronal apoptosis
27. NMDA-dependent superoxide production and neurotoxicity
28. Interaction of the N-methyl-D-aspartate receptor complex with a novel synapse-associated protein, SAP102
29. Inhibition of proteolysis protects hippocampal neurons from ischemia
30. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
31. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures
32. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina
33. Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers
34. Blockade of nitric oxide formation by N-ω-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats
35. Excitatory transmitter neurotoxicity
36. NMDA antagonist neurotoxicity: Mechanism and prevention
37. The calcium ion and cell death
38. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats
39. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data
40. (S)-4C3HPG reduces infarct size after focal cerebral ischemia
41. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents - Toward an understanding of their favorable tolerability
42. Degeneration of neurons in the thalamic reticular nucleus following transient ischemia due to raised intracranial pressure: Excitotoxic degeneration mediated via non-NMDA receptors?
43. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein
44. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: Role of mitochondria
45. Neuroprotective effect of high glucose against NMDA, free radical, and oxygen-glucose deprivation through enhanced mitochondrial potentials
46. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia
47. Calcium, excitotoxins, and neuronal death in the brain
48. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain
49. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor
50. Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons
51. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases
52. Some chemical highlights in the development of excitatory amino acid pharmacology
53. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors
54. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists
55. Dextromethorphan protects retina against ischemic injury in vivo. Dextromethorphan protects retina against ischemic injury in vivo